135 related articles for article (PubMed ID: 4790485)
1. [Current treatment of the Parkinsonian syndrome].
Voiculescu V
Neurol Psihiatr Neurochir; 1973; 18(6):519-23. PubMed ID: 4790485
[No Abstract] [Full Text] [Related]
2. [Therapy of Parkinsonian syndrome using L-dopa. Current state and problems].
Fischer PA
Nervenarzt; 1974 Dec; 45(12):617-27. PubMed ID: 4614096
[No Abstract] [Full Text] [Related]
3. [Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].
Guillard A
Brux Med; 1972 Oct; 52(10):673-80. PubMed ID: 4656191
[No Abstract] [Full Text] [Related]
4. [Treatment of the parkinsonian syndrome with L-dopa and amantadine].
Pendefunda GH; Pollingher B; Stefanache F; Gavril A; Oprişan C; Merling M; Nemţeanu E; Ciuntu M; Koropitzer I
Neurol Psihiatr Neurochir; 1973; 18(6):559-68. PubMed ID: 4790488
[No Abstract] [Full Text] [Related]
5. [Drug therapy of Parkinson's diseases].
Lhermitte F; Degos CF
Acquis Med Recent; 1972; ():73-80. PubMed ID: 4667798
[No Abstract] [Full Text] [Related]
6. [Combination therapy of Parkinson's syndrome using L-dopa and a decarboxylase inhibitor].
Fischer PA; Schneider E; Jacobi P; Maxion H
Med Welt; 1973 Nov; 24(45):1742-6. PubMed ID: 4768206
[No Abstract] [Full Text] [Related]
7. [Indications and results of monoamine treatment in parkinsonian syndromes].
Boudin G; Pépin B; Guillard A; Fabiani JM; Haguenau M
Rev Neurol (Paris); 1972 Jul; 127(1):79-97. PubMed ID: 4520464
[No Abstract] [Full Text] [Related]
8. [Progress in therapy of Parkinsonian syndrome].
Völler GW
Hippokrates; 1975 Feb; 46(1):17-33. PubMed ID: 1091605
[No Abstract] [Full Text] [Related]
9. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
Schneider E; Fischer PA; Jacobi P
Med Klin; 1974 Mar; 69(13):541-5. PubMed ID: 4831456
[No Abstract] [Full Text] [Related]
10. [Medical treatment of Parkinson's disease].
Castaigne P; Rondot P; Ribadeau-Dumas JL
Ann Med Interne (Paris); 1972 Apr; 123(4):357-64. PubMed ID: 5077040
[No Abstract] [Full Text] [Related]
11. [Accomplishment of the treatment and evaluation of treatment alternatives in parkinsonism].
Presthus J
Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2119. PubMed ID: 4773985
[No Abstract] [Full Text] [Related]
12. [Treatment of Parkinson's syndrome with L-dopa].
Kaeser HE; Ferel D; Wurmser P
Schweiz Med Wochenschr; 1970 May; 100(19):805-13. PubMed ID: 4924276
[No Abstract] [Full Text] [Related]
13. [Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].
Steinhäusl H
Wien Med Wochenschr; 1973 Jun; 123(26):433-5. PubMed ID: 4578743
[No Abstract] [Full Text] [Related]
14. [Current medical treatment of Parkinsonian syndromes].
Cincă I; Bulandra R; Serbănesco A; Ninosu N
Rev Roum Neurol; 1973; 10(4):257-85. PubMed ID: 4767886
[No Abstract] [Full Text] [Related]
15. [Conservative therapy in the Parkinson syndrome].
Birkmayer W
Wien Med Wochenschr; 1971 Nov; 121(46):827-9. PubMed ID: 5138823
[No Abstract] [Full Text] [Related]
16. [Present-day treatment of parkinsonism in the aged].
Siegfried J
Schweiz Rundsch Med Prax; 1973 Oct; 62(40):1202-3. PubMed ID: 4754539
[No Abstract] [Full Text] [Related]
17. [Problematic long-term therapy of Parkinson's syndrome using amantadine salts].
Diehl LW
Med Welt; 1975 Nov; 26(48):2188-91. PubMed ID: 813085
[No Abstract] [Full Text] [Related]
18. Levodopa and related drugs.
Med Lett Drugs Ther; 1973 Mar; 15(5):21-3. PubMed ID: 4697470
[No Abstract] [Full Text] [Related]
19. [Modalities of treatment of Parkinsonian syndrome with L-dopa].
Yanniotis G; Eisenring JJ; Gauthier G; Tissot R; de Ajuriaguerra J
Int J Neurol; 1972; 9(1):23-32. PubMed ID: 5086635
[No Abstract] [Full Text] [Related]
20. [Treatment of Parkinson's syndrome using L-dopa. 2].
Glabb J; Hübner W; Glabb S
Z Arztl Fortbild (Jena); 1973 Aug; 67(15):745-53. PubMed ID: 4594383
[No Abstract] [Full Text] [Related]
[Next] [New Search]
